These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 30885648

  • 1. Design and synthesis of novel steroidal imidazoles as dual inhibitors of AR/CYP17 for the treatment of prostate cancer.
    Hou Q, He C, Lao K, Luo G, You Q, Xiang H.
    Steroids; 2019 Oct; 150():108384. PubMed ID: 30885648
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Modeling androgen receptor flexibility: a binding mode hypothesis of CYP17 inhibitors/antiandrogens for prostate cancer therapy.
    Gianti E, Zauhar RJ.
    J Chem Inf Model; 2012 Oct 22; 52(10):2670-83. PubMed ID: 22924551
    [Abstract] [Full Text] [Related]

  • 8. Design, synthesis and biological evaluation of novel 3-oxo-4-oxa-5α-androst-17β-amide derivatives as dual 5α-reductase inhibitors and androgen receptor antagonists.
    Lao K, Sun J, Wang C, Wang Y, You Q, Xiao H, Xiang H.
    Bioorg Med Chem Lett; 2017 Sep 01; 27(17):4212-4217. PubMed ID: 28757062
    [Abstract] [Full Text] [Related]

  • 9. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
    Long BJ, Grigoryev DN, Nnane IP, Liu Y, Ling YZ, Brodie AM.
    Cancer Res; 2000 Dec 01; 60(23):6630-40. PubMed ID: 11118046
    [Abstract] [Full Text] [Related]

  • 10. 20-Aminosteroids as a novel class of selective and complete androgen receptor antagonists and inhibitors of prostate cancer cell growth.
    Fousteris MA, Schubert U, Roell D, Roediger J, Bailis N, Nikolaropoulos SS, Baniahmad A, Giannis A.
    Bioorg Med Chem; 2010 Oct 01; 18(19):6960-9. PubMed ID: 20826091
    [Abstract] [Full Text] [Related]

  • 11. Structure-activity relationship of novel (benzoylaminophenoxy)phenol derivatives as anti-prostate cancer agents.
    Kazui Y, Fujii S, Yamada A, Ishigami-Yuasa M, Kagechika H, Tanatani A.
    Bioorg Med Chem; 2018 Oct 01; 26(18):5118-5127. PubMed ID: 30228001
    [Abstract] [Full Text] [Related]

  • 12. Computational prediction of new CYP17 inhibitors based on pharmacophore modeling, virtual screening and docking approach.
    Haidar S, Hartmann RW.
    Pharmazie; 2017 Sep 01; 72(9):529-536. PubMed ID: 29441980
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. New benzothieno[2,3-c]pyridines as non-steroidal CYP17 inhibitors: design, synthesis, anticancer screening, apoptosis induction, and in silico ADME profile studies.
    Khalil NA, Ahmed EM, Zaher AF, Sobh EA, El-Sebaey SA, El-Zoghbi MS.
    J Enzyme Inhib Med Chem; 2021 Dec 01; 36(1):1839-1859. PubMed ID: 34338119
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. P450-dependent enzymes as targets for prostate cancer therapy.
    De Coster R, Wouters W, Bruynseels J.
    J Steroid Biochem Mol Biol; 1996 Jan 01; 56(1-6 Spec No):133-43. PubMed ID: 8603034
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The role of fluorine substitution in biphenyl methylene imidazole-type CYP17 inhibitors for the treatment of prostate carcinoma.
    Hu Q, Negri M, Olgen S, Hartmann RW.
    ChemMedChem; 2010 Jun 07; 5(6):899-910. PubMed ID: 20437447
    [Abstract] [Full Text] [Related]

  • 19. Design, synthesis and anti-tumor evaluation of novel steroidal glycoconjugate with furoxan derivatives.
    Li H, Wang K, Wan Q, Chen Y.
    Steroids; 2019 Jan 07; 141():81-95. PubMed ID: 30521816
    [Abstract] [Full Text] [Related]

  • 20. Fe(iii)-Catalyzed synthesis of steroidal imidazoheterocycles as potent antiproliferative agents.
    Samanta S, Ghosh AK, Ghosh S, Ilina AA, Volkova YA, Zavarzin IV, Scherbakov AM, Salnikova DI, Dzichenka YU, Sachenko AB, Shirinian VZ, Hajra A.
    Org Biomol Chem; 2020 Aug 07; 18(29):5571-5576. PubMed ID: 32662797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.